Eyeworld

SEP 2020

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1282091

Contents of this Issue

Navigation

Page 6 of 58

Gene therapy 35 Exploring corneal genetics and gene editing With options for CRISPR gene editing in the works, experts are excited about its potential application to Fuchs dystrophy, TGFBI disorders, and more 30 Gene therapy making progress in ophthalmology Physicians share how gene therapy has the potential to be a "one-and-done" treatment for rare retinal disorders and disorders with a significant treatment burden 33 Genetic testing for keratoconus Ophthalmologists discuss a test to look for genetic markers for keratoconus as well as several other corneal dystrophies 37 Stem cell replacement therapies for the eye Researchers are looking at cultivated stem cells for limbal stem cell deficiency as well as replacement photoreceptor cells for transplant for retinal conditions ASCRS SEPTEMBER 2020 • VOLUME 25 • NUMBER 7 IN FOCUS 4 | EYEWORLD | SEPTEMBER 2020

Articles in this issue

Archives of this issue

view archives of Eyeworld - SEP 2020